Regulation of Liver Glucose and Lipid Metabolism by Transcriptional Factors and Coactivators

Balamurugan Ramatchandirin, Alexia Pearah, Ling He

Research output: Contribution to journalReview articlepeer-review


The prevalence of nonalcoholic fatty liver disease (NAFLD) worldwide is on the rise and NAFLD is becoming the most common cause of chronic liver disease. In the USA, NAFLD affects over 30% of the population, with similar occurrence rates reported from Europe and Asia. This is due to the global increase in obesity and type 2 diabetes mellitus (T2DM) because patients with obesity and T2DM commonly have NAFLD, and patients with NAFLD are often obese and have T2DM with insulin resistance and dyslipidemia as well as hypertriglyceridemia. Excessive accumulation of triglycerides is a hallmark of NAFLD and NAFLD is now recognized as the liver disease component of metabolic syndrome. Liver glucose and lipid metabolisms are intertwined and carbon flux can be used to generate glucose or lipids; therefore, in this review we discuss the important transcription factors and coactivators that regulate glucose and lipid metabolism.

Original languageEnglish (US)
Article number515
Issue number2
StatePublished - Feb 2023


  • fatty liver
  • obesity
  • type 2 diabetes

ASJC Scopus subject areas

  • General Biochemistry, Genetics and Molecular Biology
  • Ecology, Evolution, Behavior and Systematics
  • Palaeontology
  • Space and Planetary Science


Dive into the research topics of 'Regulation of Liver Glucose and Lipid Metabolism by Transcriptional Factors and Coactivators'. Together they form a unique fingerprint.

Cite this